Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early deathEli Muchtar, Angela Dispenzieri, Morie A. Gertz et al.|Blood|2017Cited by 340
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteriaArjun Lakshman, Shaji Kumar, Morie A. Gertz et al.|Blood Cancer Journal|2018Cited by 288
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq AnalysisLijun Yao, Li Ding, Reyka G. Jayasinghe et al.|Cancer Research Communications|2022Cited by 40
Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal ImplicationsCharalampos Charalampous, Taxiarchis Kourelis|Frontiers in Oncology|2022Cited by 31
Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myelomaCharalampos Charalampous, Shaji Kumar, Utkarsh Goel et al.|Blood Advances|2022Cited by 26